Palliation of Dyspnea With Mouth Piece Ventilation
Not Applicable
Terminated
- Conditions
- Dyspnea
- Interventions
- Device: Trilogy 100 ® (Philips Respironics)
- Registration Number
- NCT03012737
- Lead Sponsor
- Tampere University Hospital
- Brief Summary
An uncontrolled feasibility study on using mouth piece ventilation in palliation of dyspnea in subjects with incurable advanced disease. Subjects are recruited from a local Hospice and from oncology ward. The main outcomes are the compliance of the subjects with the treatment and alleviation of dyspnea during the treatment period.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
- at least moderate dyspnea (NRS = Numeric Rating Scale ≥ 4)
- incurable advanced disease
- able to understand the study and to give informed consent
- would not gain from intensive care or resuscitation according to the treating physician
Exclusion Criteria
- unable to participate and use MPV due to e.g. delirium or lack of co-operation
- the cause of the dyspnea can be succesfully treated
- unable to give informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description MPV arm Trilogy 100 ® (Philips Respironics) Subjects use mouth piece ventilation (MPV) accoring to their will to alleviate dyspnea for 24 hours.
- Primary Outcome Measures
Name Time Method Change in dyspnea after initial use of MPV 5 - 60 min
- Secondary Outcome Measures
Name Time Method Change in dyspnea after 24 hours of using MPV 24 hours Proportion of subjects gaining from MPV 24 hours Proportion of subjects having side-effects or not being compliant with MPV 24 hours Proportion of subjects willing to continue on MPV after the intervention 24 hours
Trial Locations
- Locations (2)
Dpt of oncology, Tampere University Hospital
🇫🇮Tampere, Finland
Pirkanmaa Hospice
🇫🇮Tampere, Finland